Pedro Castelo-Branco Selected Research

Pedro Castelo-Branco Research Topics

Disease

25	Neoplasms (Cancer) 11/2022 - 06/2008
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 09/2021 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 02/2017 - 01/2016
2	Breast Neoplasms (Breast Cancer) 12/2022 - 03/2019
2	Carcinogenesis 12/2022 - 03/2018
2	Fibrosis (Cirrhosis) 01/2022 - 01/2018
2	Sepsis (Septicemia) 01/2020 - 01/2020
2	Tics (Tic) 12/2014 - 01/2011
2	Brain Neoplasms (Brain Tumor) 05/2014 - 02/2012
1	Infertility (Sterility) 01/2022
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Communicable Diseases (Infectious Diseases) 06/2021
1	Infections 01/2020
1	Critical Illness (Critically Ill) 01/2020
1	Microsatellite Instability 05/2018
1	Turcot syndrome 05/2018
1	Lung Neoplasms (Lung Cancer) 03/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2018
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2018
1	Necrosis 01/2018
1	Teratoma (Teratoid Tumor) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2017
1	Urologic Neoplasms (Urological Cancer) 02/2017
1	Chromothripsis 06/2016
1	Genomic Instability 06/2016
1	Medulloblastoma 12/2014
1	Ependymoma 12/2014
1	Diffuse Intrinsic Pontine Glioma 05/2014
1	Disease Progression 05/2013
1	Glioblastoma (Glioblastoma Multiforme) 01/2012
1	Intellectual Disability (Idiocy) 01/2012
1	Glioma (Gliomas) 01/2011

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2013
7	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2021 - 01/2011
6	MicroRNAs (MicroRNA)IBA 01/2022 - 02/2017
6	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 02/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 06/2008
2	Histone Deacetylase InhibitorsIBA 02/2017 - 06/2008
2	imetelstatIBA 12/2014 - 01/2011
2	Histones (Histone)IBA 05/2014 - 01/2012
1	CollagenIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 12/2021
1	cemiplimabIBA 12/2021
1	Angiopoietin-2IBA 01/2020
1	EnzymesIBA 01/2020
1	Complement C3 (C3 Complement)IBA 01/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	LactoperoxidaseIBA 01/2020
1	Estrogen ReceptorsIBA 03/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	CytokinesIBA 01/2019
1	ChemokinesIBA 01/2019
1	Complement System Proteins (Complement)IBA 03/2018
1	CarcinogensIBA 03/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Histone DemethylasesIBA 02/2017
1	Antisense OligonucleotidesIBA 02/2017
1	MethyltransferasesIBA 02/2017
1	Monoclonal AntibodiesIBA 01/2016
1	NivolumabIBA 01/2016
1	Programmed Cell Death 1 ReceptorIBA 01/2016
1	LithiumIBA 12/2014
1	Radiation-Sensitizing AgentsIBA 12/2014
1	RibonucleoproteinsIBA 12/2014
1	dipinacoline glutamateIBA 05/2014
1	RNA (Ribonucleic Acid)IBA 02/2012
1	ChromatinIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	HeterochromatinIBA 01/2012
1	theasinensin AIBA 06/2008
1	Cyclin D1IBA 06/2008
1	trichostatin A (A 300)IBA 06/2008

Therapy/Procedure

15	Therapeutics 11/2022 - 06/2008
3	Drug Therapy (Chemotherapy) 12/2021 - 12/2014
2	Immunotherapy 12/2021 - 05/2018
1	Lymph Node Excision (Lymph Node Dissection) 01/2018
1	Precision Medicine 02/2017
1	Transcutaneous Electric Nerve Stimulation (TENS) 06/2016
1	Withholding Treatment 01/2011